Epidemiology and natural course of social fears and social phobia.

Epidemiology and natural course of social fears and social phobia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Epidemiology and natural course of social fears and social phobia. Abstract Text:

H-U Wittchen,L Fehm,

OBJECTIVE: To summarize epidemiological studies providing data on prevalence, incidence, comorbidity, natural course, risk factors and consequences of social phobia (SP). METHOD: Data from cross-sectional studies and prospective longitudinal studies in particular are considered. RESULTS: These studies portray SP as a frequent mental disorder, which begins typically in early adolescence, and is highly comorbid with other anxiety disorders, as well as secondary depression and substance abuse disorders. Several possible risk factors have already been identified for the onset and unfavorable course of SP; some of them have been tested in prospective longitudinal studies. SP is a chronic disorder when compared with other mental disorders and when subclinical symptomatic levels are considered. Impairment caused by SP is considerable and increases over a patient's life span. The negative impact of SP is not only reflected in subjective well-being and reduced quality of life but also in social role functioning, and it impacts negatively on career progression. CONCLUSION: Prospective longitudinal studies in representative samples drawn from the general population provide information that allows the overall direct and indirect costs of the disorder (treatment costs, disability, social welfare) to be determined, and enables an improvement in long-term care strategies as well as preventive efforts to be established.

Epidemiology and natural course of social fears and social phobia. Publishing Authors By Initials

HU Wittchen,L Fehm,

For similar behavior and behavior mechanisms: behavior: social behavior research abstracts see: behavior and behavior mechanisms: behavior: social behavior research

PUBMED ID PMID:

MEDLINE DATE:

Epidemiology and natural course of social fears and social phobia. Journal Published:

PUBLICATION TYPE: Review

Journal: Acta psychiatrica Scandinavica. Supplementum

VOLUME:

Page Numbers: 4-18

Journal Abbreviation:

ISSN: 0065-1591

DAY: 15

MONTH: 02

YEAR: 2003

Epidemiology and natural course of social fears and social phobia. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370365

Epidemiology and natural course of social fears and social phobia. Keywords Mesh Terms:

KEYWORDS: Social Behavior

MESH TERMS: psychology

Chemical & Substance for Abstract: Epidemiology and natural course of social fears and social phobia. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Epidemiology and natural course of social fears and social phobia.

AFFILIATION: Department of Clinical Psychology and Psychotherapy, Dresden University of Technology, Chemnitzer Str. 46, Dresden, Germany. wittchen@mpipsykl.mpg.de

Country: Denmark

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Acta Psychiatr Scand Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Epidemiology and natural course of social fears and social phobia Related Publications

• Acute twin-twin transfusion syndrome: a case report.
• Changes in tumour biological markers during primary systemic chemotherapy (PST).
• Disturbed cortisol secretion in man: contrasting Cushing's disease and endogenous depression.
• Dose-dependent influences on electrophysiological signs of attention in humans after neuropeptide ACTH 4-10.
• Down-regulation of CD28, TCR-zeta (zeta) and up-regulation of FAS in peripheral cytotoxic T-cells of primary breast cancer patients.
• Epidemiology and natural course of social fears and social phobia.
• Glucocorticoid influences on the auditory brain-stem responses in man.
• Predicting resistance to platinum-containing chemotherapy with the ATP tumor chemosensitivity assay in primary ovarian cancer.
• Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients.
• Tumor cell dormancy: implications for the biology and treatment of breast cancer.